Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKATE: Keppra Adjunctive Therapy in Epilepsy
NCT00630968Phase 4Completed
- Sponsor
- UCB
- Start
- Aug 2000
- Primary completion
- Feb 2004
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of levetiracetam in partial epilepsy, sponsored by UCB. Primary endpoint: Percentage reduction in seizure frequency at 16 weeks. Started Aug 2000; status: completed.
02
Drugs
levetiracetam
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00630968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630968.